Radiosensitization by a novel Bcl-2 and Bcl-X L inhibitor S44563 in small-cell lung cancer | Cell Death & Disease
Bcl-2 and Bcl-xL Inhibit CD95-mediated Apoptosis by Preventing Mitochondrial Release of Smac/DIABLO and Subsequent Inactivation of X-linked Inhibitor-of-Apoptosis Protein* - Journal of Biological Chemistry
Selective targeting of antiapoptotic BCL‐2 proteins in cancer - Timucin - 2019 - Medicinal Research Reviews - Wiley Online Library
Dual Inhibition of Bcl-2 and Bcl-xL Strikingly Enhances PI3K Inhibition-Induced Apoptosis in Human Myeloid Leukemia Cells through a GSK3- and Bim-Dependent Mechanism | Cancer Research
Co-inhibition of BCL-XL and MCL-1 with BCL-2 selective inhibitors A1331852 and S63845 enhances cytotoxicity of cervical cancer cell lines | bioRxiv
Targeting BCL-xL improves the efficacy of bromodomain and extra-terminal protein inhibitors in triple-negative breast cancer by eliciting the death of senescent cells - Journal of Biological Chemistry
Exploiting selective BCL-2 family inhibitors to dissect cell survival dependencies and define improved strategies for cancer therapy | Science Translational Medicine
The apoptosis inhibitor Bcl-xL controls breast cancer cell migration through mitochondria-dependent reactive oxygen species production.,Oncogene - X-MOL